Psoriasis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Psoriasis Clinical Trials Market Overview
The psoriasis clinical trial market research report provides an overview of the psoriasis clinical trials scenario. The report provides top-line data relating to the clinical trials on psoriasis. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
Psoriasis Clinical Trials Market Segmentation by Regions and Countries
The key regions in the psoriasis clinical trials market are Europe, Asia-Pacific, North America, the Middle East & Africa, and South & Central America. Of all the clinical trials conducted on psoriasis, as of January 2023, more than 30% of the clinical trials were conducted in Europe, followed by the Asia-Pacific.
In a country-wise analysis, as of January 2023, the US has the highest number of psoriasis clinical trials, followed by Germany, China, Canada, the UK, France, Poland, India, Japan, and Spain.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, Canada has the highest proportion of psoriasis to immunology clinical trials as of January 2023. Out of all the clinical trials conducted in the G7 countries, the majority were in the US.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, India has the highest proportion of psoriasis to immunology clinical trials as of January 2023. Out of all the clinical trials conducted in the E7 countries, the majority were in China.
Psoriasis Clinical Trials Analysis by Regions, 2023 (%)
For more regional insights into the psoriasis clinical trials market, download a free report sample
Psoriasis Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the psoriasis clinical trials market are institution, company, and the government. Out of them, the company sponsor type dominates the market.
Psoriasis Clinical Trials Market Analysis by Sponsor Types, 2023 (%)
For more sponsor type insights into the psoriasis clinical trials market, download a free report sample
Psoriasis Clinical Trials Market - Competitive Landscape
The leading sponsors in the psoriasis clinical trials market are Novartis AG, AbbVie Inc, Johnson & Johnson, LEO Foundation, Pfizer Inc, Amgen Inc, Eli Lilly and Co, Bristol-Myers Squibb Co, C. H. Boehringer Sohn AG & Co KG, and GSK plc. Novartis AG has conducted the highest number of psoriasis clinical trials and is followed by AbbVie Inc and Johnson & Johnson.
Psoriasis Clinical Trials Market Analysis by Sponsors, 2023 (%)
To know more about the leading players in the psoriasis clinical trials market, download a free report sample
Psoriasis Clinical Trials Market Report Overview
Key Regions | Europe, Asia-Pacific, North America, Middle East & Africa, and South & Central America |
Key Countries | The US, Germany, China, Canada, the UK, France, Poland, India, Japan, and Spain |
Key Sponsor Types | Institution, Company, and Government |
Leading Sponsors | Novartis AG, AbbVie Inc, Johnson & Johnson, LEO Foundation, Pfizer Inc, Amgen Inc, Eli Lilly and Co, Bristol-Myers Squibb Co, C. H. Boehringer Sohn AG & Co KG, and GSK plc |
Segments Covered in the Report
Psoriasis Clinical Trials Regional Outlook (2023)
- Asia-Pacific
- North America
- Europe
- Middle East & Africa
- South & Central America
Psoriasis Clinical Trials Country Outlook (2023)
- The US
- Germany
- China
- Canada
- The UK
- France
- Poland
- India
- Japan
- Spain
Psoriasis Clinical Trials Sponsor Type Outlook (2023)
- Institution
- Company
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and end-point status
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with reasons for unaccomplishment
- The report provides enrollment trends for the past five years
- The report provides the latest news for the past three months
Reasons to Buy
- Assists in formulating key business strategies with regard to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top-level analysis of the Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in the global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional, and country level
AbbVie Inc
Johnson & Johnson
LEO Foundation
Pfizer Inc
Amgen Inc
Eli Lilly and Co
Bristol-Myers Squibb Co
C. H. Boehringer Sohn AG & Co KG
GSK plc
Table of Contents
Table
Figures
Frequently asked questions
-
Which are the key regions in the psoriasis clinical trials market?
The key regions in the psoriasis clinical trials market are Europe, Asia-Pacific, North America, the Middle East & Africa, and South & Central America.
-
Which are the key countries in the psoriasis clinical trials market?
The key countries in the psoriasis clinical trials market are the US, Germany, China, Canada, the UK, France, Poland, India, Japan, and Spain.
-
What are the key sponsor types in the psoriasis clinical trials market?
The key sponsor types in the psoriasis clinical trials market are institution, company, and the government.
-
Who are the leading sponsors in the psoriasis clinical trials market?
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.